Uses
Anti-phospho-PAK1 (pThr
212) may be used for immunoblotting at a working concentration of 0.2-0.4 μg/mL. The antibody is also suitable for indirect ELISA, immunocytochemistry and protein microarray.
General Description
Monoclonal Anti-Phospho-PAK1 (pThr212) (mouse IgG1 isotype) is derived from the PK-18 hybridoma produced by the fusion of mouse myeloma cells and splenocytes from BALB/c mice immunized with a synthetic peptide corresponding to amino acids of human PAK1,1 conjugated to keyhole limpet hemocyanin (KLH). PAK1 (p21-activated kinase 1) is homologous to Sacharomyces cerevisiae kinase Ste20. PAK1 (68 kDa),with a C-terminal serine/threonine kinase domain and a N-terminal CRIB (Cdc42/Rac interactive binding) domain. Thr212 localized in flexible region is of PAK1 domain.
Biochem/physiol Actions
p21-activated kinase 1 (PAK1) also regulates cytoskeletal dynamics by decreasing MLCK (myosin light chain kinase) activity and MLC phosphorylation. PAK1 is reported to be a crucial signaling molecule, involved in the transcription factor nuclear factor κB (NFκB) activation by multiple stimuli. PAK1 regulates cell morphology and polarity in eukaryotic cells and activates downstream targets like JNK (c-Jun N-terminal protein kinase) and p38 mitogen-activated protein kinase (MAPK).. The phosphorylation of actin by PAK1 at thr212 helps in regulating growth cone dynamics.
